Tumor Size Nadir and Time to Nadir as Surrogates for OS in Patients on 1st Line Treatment for mCRC

January 17, 2017

San Francisco, CA, USA

Burzykowski T, Buyse M. Tumor size nadir and time to nadir as surrogates for OS in patients on 1st line treatment for mCRC. Invited lecture at the meeting of ARCAD « Aide et Recherche en Cancérologie Digestive»..

Powered by Atypic ®

IDDI